PT BIOMETRIK RISET INDONESIA AT CPHI KOREA 2026: THE LEADING COMPANY IN BIOEQUIVALENCE STUDY GOES GLOBAL

Writer & Editor: Canaya Vania Rehansha

Seoul, August 2026 – PT BIOMETRIK RISET INDONESIA AT CPHI KOREA 2026: THE LEADING COMPANY IN BIOEQUIVALENCE STUDY GOES GLOBAL

Strengthening Global Connections and Exploring New Collaborations

Seoul, South Korea – PT Biometrik Riset Indonesia successfully concluded its participation at CPHI Korea 2026, strengthening its presence as The Leading Company in Bioequivalence Study and expanding its network within the global pharmaceutical industry.

Throughout the event, the Biometrik team actively connected with pharmaceutical companies and industry professionals through discussions, networking sessions, and business meetings. The event provided valuable opportunities to introduce Biometrik's capabilities in Bioavailability/Bioequivalence (BA/BE) studies and explore potential international collaborations.

Building Meaningful Global Partnerships

Beyond the exhibition and seminar activities, Biometrik conducted productive discussions with international industry partner.These meetings created opportunities to exchange insights and explore potential future collaborations.

The participation also included a seminar session highlighting Biometrik's experience and expertise in conducting Bioequivalence Studies, demonstrating the company's commitment to contributing knowledge and strengthening Indonesia's presence in the international pharmaceutical research industry.

Moving Forward

CPHI Korea 2026 marks another important milestone in Biometrik's journey toward expanding its global network and developing meaningful international partnerships.

As The Leading Company in Bioequivalence Study, PT Biometrik Riset Indonesia remains committed to delivering high-quality research services and connecting Indonesia's pharmaceutical research capabilities with the global market.

Thank you to everyone who visited, connected, and shared valuable discussions with us during CPHI Korea 2026. We look forward to future collaborations!